Photo credit: P. Morris/Garvan
The Kinghorn Centre for Clinical Genomics (KCCG) was established by the Garvan Institute in 2012 to advance the use of genomic information in patient care. KCCG employs world-leading DNA sequencing technology and expertise in genetics, pathology and bioinformatics to deliver and interpret genome sequences for research and clinical use. Find out more about our mission and vision in About KCCG.
KCCG acts as a mechanism to translate genomic research into the clinic, and has recently obtained accreditation to enable it to provide state-of-the-art interpretation of genomic data directly to clinicians. From the 1st of August 2016, clinical whole genome sequencing services for diagnosis of rare and genetic disease is available through Garvan's wholly owned subsidiary company, Genome.One.
Public and professional engagement will be vital to realising the potential of clinical genomics in Australia, and the Centre is developing programs, resources and opportunities for health practitioners and communities to learn about genomics.
Technology and Partnerships
In 2014, Garvan acquired a HiSeq X Ten sequencing platform, which provides KCCG with powerful genome sequencing potential and the capability to sequence up to 18,000 whole human genomes per year. Researchers with ethically-approved projects can order genomes from our facility. In 2014, the Centre became a genomics node of BioPlatforms Australia.
is focused on improving the value and interpretation of genomes for patient care. The Centre will continue to facilitate genome-based research, initially in cancer and monogenic diseases, but also in complex disease such as diabetes, osteoporosis and immunological disease. at the KCCG
In the News
International experts share insights into genomic healthcare at Australia’s first clinical genomics symposium - Dec 20, 2016
Genomes of healthy older Australians to accelerate medical research in NSW and beyond - Dec 16, 2016
New Centre for Research Excellence to transform diagnosis and management of severe neurocognitive disorders - Dec 05, 2016
NHMRC: grants success for Garvan researchers - Dec 05, 2016
Garvan Institute achieves major milestone: 10,000 genomes sequenced - Oct 18, 2016
Alan's story: a life-changing diagnosis through genome sequencing (UPDATED) - Sep 24, 2016
Cancer Institute NSW grant brings advanced genomics technology to Australia - Sep 19, 2016
NSW leadership in the global advance of clinical genomics - Aug 29, 2016
New era in genetic disease diagnosis with Australia’s first whole-genome testing service to be launched today - Jul 27, 2016
Garvan team a top performer in international genomics challenge - Jul 06, 2016
2016 Shine Translational Research Fellowship awarded - May 21, 2016
Landmark Lions project to provide genome sequencing to hundreds of Aussie kids with cancer - May 14, 2016
MyGene2 website reaches Open Science Prize final - May 12, 2016
NSW Health collaborative genomics grants announced - Apr 27, 2016
Handling big data in genomics: Garvan partners with NCI - Feb 25, 2016
45 and Up: working with Australia’s biggest health study - Nov 18, 2015
NHMRC funding success for Garvan researchers - Nov 09, 2015
Garvan gets behind Movember - Nov 05, 2015
Garvan partners with Genomics England - Sep 25, 2015
Genomics initiative to help children with genetic disorders - Sep 10, 2015
Garvan researchers benefit from Cancer Institute NSW equipment funding - Aug 31, 2015
Garvan Institute welcomes NSW funding of Sydney Genomics Collaborative - Jun 17, 2014
The future of genomic medicine has arrived in Australia - Jan 15, 2014
Garvan wins Hitachi Data Systems APAC Health and Life Sciences Innovation Award - Aug 30, 2013